Association between the use of proton pump inhibitors and cardiovascular events: A note of caution

被引：0
作者：
Raschi, E. [1 ]
Bianchin, M. [1 ]
Poluzzi, E. [1 ]
De Ponti, F. [1 ]
机构：
[1] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy
来源：
NEUROGASTROENTEROLOGY AND MOTILITY | 2017年 / 29卷 / 02期
关键词：
MYOCARDIAL-INFARCTION; METAANALYSIS; RISK;
D O I：
10.1111/nmo.12977
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
[41]   Association between exposure to proton pump inhibitors and delirium: a descriptive and disproportionality analysis of VigiBase [J].
Decros, Alexandre ;
Minoc, Elise-Marie ;
Lelong-Boulouard, Veronique ;
Chretien, Basile ;
Meurant, Alexandre ;
Alexandre, Joachim ;
Dolladille, Charles ;
Villain, Cedric .
BMJ OPEN, 2024, 14 (10)
[42]   Association Between Proton Pump Inhibitors and Asthma: A Population-Based Cohort Study [J].
Wang, Yao-Tung ;
Tsai, Ming-Chang ;
Wang, Yu-Hsun ;
Wei, James Cheng-Chung .
FRONTIERS IN PHARMACOLOGY, 2020, 11
[43]   REPLY TO: ASSOCIATION BETWEEN PROTON PUMP INHIBITORS AND ALZHEIMER'S DISEASE IN OLDER ADULTS [J].
Goldstein, Felicia C. .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2018, 66 (09) :1850-1850
[44]   Cardiovascular and gastrointestinal events of three antiplatelet therapies: clopidogrel, clopidogrel plus proton-pump inhibitors, and aspirin plus proton-pump inhibitors in patients with previous gastrointestinal bleeding [J].
Tsai, Yi-Wen ;
Wen, Yu-Wen ;
Huang, Weng-Foung ;
Chen, Pei-Fen ;
Kuo, Ken N. ;
Hsiao, Fei-Yuan .
JOURNAL OF GASTROENTEROLOGY, 2011, 46 (01) :39-45
[45]   Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy [J].
Agewall, Stefan ;
Cattaneo, M. ;
Collet, J. P. ;
Andreotti, F. ;
Lip, G. Y. H. ;
Verheugt, F. W. A. ;
Huber, K. ;
Grove, E. L. ;
Morais, J. ;
Husted, S. ;
Wassmann, S. ;
Rosano, G. ;
Atar, D. ;
Pathak, A. ;
Kjeldsen, K. ;
Storey, R. F. .
EUROPEAN HEART JOURNAL, 2013, 34 (23) :1708-+
[46]   A pharmacovigilance study of the association between proton pump inhibitors and tumor adverse events based on the FDA adverse event reporting system database [J].
Zhang, Ya-Jun ;
Duan, Dan-Dan ;
Tian, Qian-Yu ;
Wang, Cai-E. ;
Wei, Shu-Xun .
FRONTIERS IN PHARMACOLOGY, 2024, 15
[47]   Potential Cardiovascular Risks of Proton Pump Inhibitors in the General Population [J].
Zhu, Wengen ;
Hong, Kui .
INTERNATIONAL HEART JOURNAL, 2017, 58 (02) :163-166
[48]   How May Proton Pump Inhibitors Impair Cardiovascular Health? [J].
Sukhovershin, Roman A. ;
Cooke, John P. .
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2016, 16 (03) :153-161
[49]   Systematic review and meta-analysis of adverse cardiovascular events associated with proton pump inhibitors used alone or in combination with antiplatelet agents [J].
Farhat, Nawal ;
Fortin, Yannick ;
Haddad, Nisrine ;
Birkett, Nicholas ;
Mattison, Donald R. ;
Momoli, Franco ;
Wen, Shi Wu ;
Krewski, Daniel .
CRITICAL REVIEWS IN TOXICOLOGY, 2019, 49 (03) :215-261
[50]   Long-term use of proton pump inhibitors - really harmless? [J].
Haag, Sebastian .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (45) :2319-2321
12345